login

Depressive relapse following acute tryptophan depletion in patients with major depressive disorder

Journal of PsychopharmacologyPublished 1 May 2000
Marco Leyton, A.M. Ghadirian, Simon N. Young, Roberta M. Palmour, Pierre Blier, Karin F. Helmers
Citations46
SJR quartileQ1
SJR score1.71
SNIP1.37

TL;DR

The hypothesis that depressed states are related to disturbed serotonin neurotransmission is supported and depressive symptoms following ATD might identify a subgroup of patients at high genetic risk for disorders associated with affective lability and dysregulated impulsecontrol, conditions thought to be related to low serotonin neurotransmissions.

Abstract

Acute tryptophan depletion (ATD) lowers serotonin synthesis and elicits depressive symptoms in some, though not all, remitted patients with major depressive disorder (MDD). In the present study, eight medication-free remitted patients with MDD, seasonal pattern, were tested twice, once following the ingestion of a tryptophan-containing mixture, once following ATD. ATD significantly increased Hamilton depression scores (p < 0.001). Four of the patients had a family history of psychiatric disorders: substance abuse (n = 4), mood disorders (n = 3) or Cluster B personality disorders (n = 3). The mood-lowering response to ATD was significantly greater in those patients with, than without, affected relatives (p < 0.001). These preliminary findings (1) support the hypothesis that depressed states are related to disturbed serotonin neurotransmission and (2) suggest that depressive symptoms following ATD might identify a subgroup of patients at high genetic risk for disorders associated with affective lability and dysregulated impulse-control, conditions thought to be related to low serotonin neurotransmission.

Keywords

PsychologyMedicineNeuroscience